Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Journal of Immunotoxicology|December 10, 2024
Using irAOP for non-clinical safety evaluation of biotechnology-derived pharmaceuticals and ATMPs: a paradigm shift into a systematic and holistic frameworkArmin Braun, Susann DehmelNeuroscience Letters|June 12, 2021
Sensory modulation of airways immunityFederica La Russa, Susann Dehmel, Armin Braun, et al.Journal of Immunotoxicology|December 10, 2024
Type 2 responses determine skin rash during recombinant interleukin-2 therapyCharline Sommer, Vanessa Neuhaus, Patricia Gogesch, et al.The Journal of Allergy and Clinical Immunology|February 8, 2019
Mast cells within cellular networksMichael Stassen, Ann-Kathrin Hartmann, Sharon Jiménez Delgado, et al.Frontiers in Immunology|August 1, 2020
From Cancer to Immune-Mediated Diseases and Tolerance Induction: Lessons Learned From Immune Oncology and Classical Anti-cancer TreatmentStephan Klöß, Susann Dehmel, Armin Braun, et al.European Journal of Immunology|March 2, 2024
Interleukin-2-induced skin inflammationCharline Sommer, Jarish N Cohen, Susann Dehmel, et al.Respiratory Research|January 4, 2024
Age-dependent inflammatory response is altered in an ex vivo model of bacterial pneumoniaCharline Sommer, Stella Marie Reamon-Buettner, Monika Niehof, et al.Genome Biology|December 15, 2023
A time-resolved meta-analysis of consensus gene expression profiles during human T-cell activationMichael Rade, Sebastian Böhlen, Vanessa Neuhaus, et al.Clinical Immunology (Orlando, Fla.)|July 1, 2024
Bridging therapy-induced phenotypes and genetic immune dysregulation to study interleukin-2-induced immunotoxicologyCharline Sommer, Sophie Jacob, Tonia Bargmann, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2023
Targeted GATA3 knockdown in activated T cells via pulmonary siRNA delivery as novel therapy for allergic asthmaRima Kandil, Domizia Baldassi, Sebastian Böhlen, et al.Pageof 2